Five-year study of benztropine (cogentin) methanesulfonate; outcome in three hundred two cases of paralysis agitans.
D001590:Benztropine; D002317:Cardiovascular Agents; D008698:Mesylates; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000628:therapy*
D002317:Cardiovascular Agents; D008698:Mesylates; D009125:Muscle Relaxants, Central; C045880:methanesulfonic acid; D001590:Benztropine
MUSCLE RELAXANTS/therapeutic use; PARALYSIS AGITANS/therapy